Ciwon daji na prostate
From Wikipedia, the free encyclopedia
Ciwon daji na prostate shine ci gaban kansa a cikin prostate, gland a cikin tsarin haihuwa na namiji.[1] Yawancin ciwon daji na prostate suna jinkirin girma; duk da haka kuma, wasu suna girma da sauri.[2][3] Kwayoyin ciwon daji na iya yaduwa daga prostate zuwa wasu sassan jiki, musamman kasusuwa da ƙwayoyin lymph.[4] Yana iya da farko ya haifar da babu alamun.[2] A mataki na gaba, yana iya haifar da wahalar fitsari, jini a cikin fitsari ko jin zafi a ƙashin ƙugu, baya, ko lokacin fitsari.[5] Cutar da aka sani da hyperplasia na prostatic na iya haifar da irin wannan alamun.[2] Sauran alamomin marigayi na iya haɗawa da jin gajiya saboda ƙarancin matakan jajayen ƙwayoyin jini.[2]
Ciwon daji na prostate | |
---|---|
Description (en) | |
Iri |
male reproductive organ cancer (en) , prostate neoplasm (en) , prostate disease (en) cuta |
Specialty (en) |
Oncology urology (en) |
Physical examination (en) |
Kallikrein related peptidase 3 (en) , positron emission tomography (en) , medical ultrasonography (en) prostate cancer screening (en) |
Genetic association (en) | MSMB (en) , KLK3 (en) , EBF2 (en) , CEP152 (en) , UPF2 (en) , DNAH12 (en) , BAIAP2L1 (en) , RNASE9 (en) , ANK2 (en) , TSEN2 (en) , EVC (en) , TNRC6B (en) , ANXA13 (en) , ABLIM1 (en) , TMTC2 (en) , TNC (en) , ZNF280B (en) , ACOXL (en) , EPHA10 (en) , KIF13A (en) , SPATA16 (en) , ZBTB38 (en) , TERT (en) , FGF10 (en) , CCHCR1 (en) , MLPH (en) , BIK (en) , FSHR (en) , TTC7A (en) , PTGFRN (en) , LRP1B (en) , AOPEP (en) , GLI2 (en) , CNNM3 (en) , FOXP4 (en) , HNF1B (en) , THADA (en) , ITGA6 (en) , PDLIM5 (en) , SLC22A3 (en) , LMTK2 (en) , EHBP1 (en) , CTBP2 (en) , JAZF1 (en) , CTDSPL (en) , PKHD1 (en) , HAPLN1 (en) , RNASEL (en) da RBM10 (en) |
Medical treatment (en) | |
Magani | ethinylestradiol (en) , finasteride (en) , flutamide (en) , mitoxantrone (en) , chlorotrianisene (en) , etoposide (en) , nilutamide (en) , bicalutamide (en) , diethylstilbestrol (en) , cisplatin (en) , 17β-estradiol (en) , leuprolide (en) , estramustine (en) , hydroxyurea (en) , (RS)-aminoglutethimide (en) , goserelin acetate (en) , doxorubicin hydrochloride (en) , cyproterone acetate (en) , zoledronic acid (en) , radium ra-223 dichloride (en) , cabazitaxel (en) da nilutamide (en) |
Identifier (en) | |
ICD-10-CM | C61 |
ICD-9-CM | 185 |
ICD-10 | C6161. |
ICD-9 | 185185 |
OMIM | 176807, 300147, 300704, 601518, 602759, 608656, 608658, 609299, 609558, 610321, 610997, 611100, 611868, 611928, 611955, 611958 da 611959 |
DiseasesDB | 10780 |
MedlinePlus | 000380 |
eMedicine | 000380 |
Disease Ontology ID | DOID:10283 |
Abubuwan da ke ƙara haɗarin cutar kansar prostate sun haɗa da tsufa, tarihin iyali na cutar, da launin fata.[3] Kimanin kashi 99% na lokuta suna faruwa a cikin maza fiye da shekaru 50.[3] Samun dangi na farko tare da cutar yana kara haɗarin sau biyu zuwa uku. Sauran abubuwan da ka iya haɗawa sun haɗa da abinci mai yawa na nama da aka sarrafa, jan nama ko madara ko ƙarancin wasu kayan lambu.[3] An sami haɗin gwiwa tare da gonorrhea, amma ba a gano dalilin wannan dangantaka ba.[6] Haɗarin haɓaka yana haɗuwa da maye gurbin BRCA.[7] Ana gano kansar prostate ta hanyar biopsy.[5] Ana iya yin hoton likita don sanin ko ciwon daji ya yadu zuwa wasu sassan jiki.[5]
Binciken kansar prostate yana da cece-kuce.[3][8] Gwajin takamaiman antigen na Prostate (PSA) yana ƙara gano cutar kansa, amma yana da rigima game da ko yana inganta sakamako.[8][9][10] Ana ba da shawarar shawarar yanke shawara idan aka zo batun tantancewa tsakanin waɗanda ke da shekaru 55 zuwa 69.[11][12] Gwaji, idan an yi shi, ya fi dacewa a cikin waɗanda ke da tsawon rai.[13] Duk da yake masu hana 5a-reductase suna bayyana don rage ƙananan haɗarin ciwon daji, ba su shafar haɗarin ciwon daji mai girma kuma don haka ba a ba da shawarar yin rigakafi ba.[3] Ƙarawa tare da bitamin ko ma'adanai ba ya bayyana yana tasiri ga hadarin.[3][14]
Yawancin lokuta ana sarrafa su tare da sa ido mai aiki ko jira a hankali.[5] Wasu jiyya na iya haɗawa da haɗin tiyata, maganin radiation, maganin hormone ko chemotherapy.[5] Lokacin da kawai ya faru a cikin prostate, ana iya warkewa.[2] A cikin wadanda cutar ta yada zuwa kasusuwa, magungunan ciwo, bisphosphonates da maganin da aka yi niyya, da sauransu, na iya zama da amfani.[5] Sakamakon ya dogara ne akan shekarun mutum da sauran matsalolin kiwon lafiya da kuma yadda ciwon daji ke da yawa.[5] Yawancin maza masu fama da cutar kansar prostate ba sa mutuwa daga cutar.[5] Adadin rayuwa na shekaru 5 a Amurka shine 98%.[15]
A duniya baki daya, ita ce nau'in ciwon daji na biyu mafi yawa kuma na biyar kan haddasa mutuwar masu alaka da cutar daji a cikin maza.[16] A cikin 2018, ya faru a cikin maza miliyan 1.2 kuma ya yi sanadiyar mutuwar 359,000.[17] Ita ce cutar sankara mafi yawa a cikin maza a cikin kasashe 84, wanda ya fi faruwa a cikin kasashen da suka ci gaba.[18] Ƙididdigar ƙima na karuwa a cikin ƙasashe masu tasowa.[19] Gano ya ƙaru sosai a cikin 1980s da 1990s a wurare da yawa saboda ƙarin gwajin PSA.[3] Nazarin mazan da suka mutu daga abubuwan da ba su da alaƙa sun sami ciwon daji na prostate a cikin 30% zuwa 70% na waɗanda suka wuce shekaru 60.[2][18]